Trending Now - Wegovy Introduces Subscription Plans to Compete in Weight Loss Market
WHO:
NBC News - Novo Nordisk is the company unveiling the subscription model for Wegovy.
CNBC - Ed Cinca is the head of marketing and patient solutions at Novo Nordisk.
WHAT:
Fast Company - A three-month subscription plan for Wegovy will cost users $329 per month, a six-month plan will cost $299 per month, and a 12-month subscription will have a monthly fee of $249.
Fast Company - The subscription program is described as the "first-of-its-kind offering" aimed at helping patients manage the costs of their treatment.
NBC News - Novo Nordisk is introducing a subscription model for self-pay customers of Wegovy.
CNBC - The subscription program offers three-, six-, or 12-month plans for Wegovy injections and pills.
CNBC - Patients can save up to $1,200 a year on the injection and up to $600 a year on the pill compared to paying for individual doses.
CNBC - The subscription program aims to provide "predictable" monthly prices for cash-paying patients.
WHERE:
CNBC - The subscription program will be available through several telehealth partners, including Ro, WeightWatchers, LifeMD, Sesame, and Hims & Hers.
WHEN:
CNBC - The subscription program was launched on March 31st, 2026.
WHY:
Fast Company - The subscription program aims to "remove barriers" and provide a "simple, affordable, and consistent way" for patients to start and stay on FDA-approved treatment.
CNBC - The subscription model is part of Novo Nordisk's effort to reduce prices and entice more patients.
CNBC - A 2025 study estimated that around 65% of patients with obesity stop treatment within a year due to issues like difficulty accessing the drugs and gastrointestinal side effects.
HOW:
Fast Company - The subscription options are available through telehealth partners Ro, WeightWatchers, LifeMD, Hims & Hers, and Sesame, with plans to expand to more services soon.
CNBC - The subscription model allows patients to pay flat monthly prices, even if they switch to different doses.
(UPDATED March 31, 2026 19:22 UTC)
Wegovy has launched a subscription program designed to help patients manage the costs of their treatment, with prices set at $329 per month for a three-month plan, $299 per month for six months, and $249 per month for a full year. This first-of-its-kind offering aims to remove barriers and provide a simple, affordable, and consistent way for patients to access FDA-approved treatment. The subscription options are available through telehealth partners like Ro, WeightWatchers, LifeMD, Hims & Hers, and Sesame, with plans to expand to more services in the near future.
--
(UPDATED March 31, 2026 17:26 UTC)
Novo Nordisk has launched a subscription model for its weight loss medication Wegovy, aimed at self-pay customers, which became available on Tuesday. The program offers three-, six-, or twelve-month plans that can save patients up to $1,200 a year on injections and up to $600 a year on pills, providing predictable monthly costs for those paying out of pocket. Patients can access this subscription through various telehealth partners, including Ro, WeightWatchers, LifeMD, Sesame, and Hims & Hers, as part of Novo Nordisk's initiative to make treatment more accessible and appealing to those struggling with obesity.